BioVie Inc.
General ticker "BIVI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $25.2M (TTM average)
BioVie Inc. does not follow the US Stock Market performance with the rate: -10.0%.
Estimated limits based on current volatility of 3.4%: low 1.51$, high 1.62$
Factors to consider:
- Total employees count: 14 (-22.2%) as of 2024
- Top business risk factors: No manufacturing experience, Labor/talent shortage/retention, Government regulations, Pandemic risks, Loss of management
- Current price 56.0% below estimated low
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [9.38$, 49.82$]
- 2025-06-30 to 2026-06-30 estimated range: [3.66$, 18.48$]
Financial Metrics affecting the BIVI estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -136.75 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: Industry earnings per price (median), % of -21.29 <= 0
Short-term BIVI quotes
Long-term BIVI plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.25MM | $45.08MM | $32.18MM |
| Operating Income | $-27.25MM | $-45.08MM | $-32.18MM |
| Non-Operating Income | $1.17MM | $-5.35MM | $-0.12MM |
| Interest Expense | $2.16MM | $4.30MM | $2.89MM |
| R&D Expense | $17.26MM | $33.30MM | $23.10MM |
| Income(Loss) | $-26.08MM | $-50.43MM | $-32.30MM |
| Profit(Loss)* | $-26.08MM | $-50.26MM | $-32.30MM |
| Stockholders Equity | $3.67MM | $15.34MM | $15.51MM |
| Assets | $20.11MM | $35.10MM | $25.21MM |
| Operating Cash Flow | $-18.99MM | $-40.25MM | $-27.95MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-14.30MM | $14.53MM |
| Financing Cash Flow | $33.12MM | $55.37MM | $17.80MM |
| Earnings Per Share** | $-105.77 | $-154.71 | $-71.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.